NPRNPR·2hHealth
score-0.60
FDA Panel to Weigh Evidence on Peptides, Seeking Clearer Safety and Efficacy Standards for Trendy Molecules
Original
FDA scientists flag concerns with peptides, the trendy molecules RFK Jr. supports
“Uses alarmist framing ('flag concerns,' 'lack of good evidence') while emphasizing regulatory contradiction, creating worry about safety oversight.”